Pharming Group NV (PHARMa)

Currency in EUR
0.9573
0.0000(0.00%)
Closed·

PHARMa Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy

Technical Indicators

Buy

Moving Averages

Buy

Summary:Buy

Moving Averages:BuyBuy: (8)Sell: (4)
Technical Indicators:BuyBuy: (5)Sell: (4)

Technical Indicators

Summary: BuyBuy: 5Neutral: 1Sell: 4
Jul 25, 2025 17:55 GMT
Name
Value
Action
RSI(14)55.654Buy
STOCH(9,6)33.104Sell
STOCHRSI(14)17.79Oversold
MACD(12,26)0.033Buy
ADX(14)48.214Buy
Williams %R-56.012Sell
CCI(14)4.3501Neutral
ATR(14)0.0314High Volatility
Highs/Lows(14)-0.0033Sell
Ultimate Oscillator40.648Sell
ROC12.227Buy
Bull/Bear Power(13)0.0086Buy

Moving Averages

Summary: BuyBuy: 8Sell: 4
Jul 25, 2025 17:55 GMT
Name
Simple
Exponential
MA5
0.9461
Buy
0.9613
Sell
MA10
0.9976
Sell
0.9548
Buy
MA20
0.9353
Buy
0.9309
Buy
MA50
0.8662
Buy
0.8886
Buy
MA100
0.8582
Buy
0.9057
Buy
MA200
0.9914
Sell
0.9610
Sell

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic0.95730.95730.95730.95730.95730.95730.9573
Fibonacci0.95730.95730.95730.95730.95730.95730.9573
Camarilla0.95730.95730.95730.95730.95730.95730.9573
Woodie's0.95730.95730.95730.95730.95730.95730.9573
DeMark's--0.95730.95730.9573--

FAQ

From a Technical Analysis Perspective, Is Pharming Group NV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Do the Moving Averages for PHARMa Currently Stand?

The moving averages for Pharming Group NV show a Buy outlook, considering moving averages ranging from MA5 to MA200, with 8 Buy signals and 4 Sell signals.

What Is the Current Status of the Technical Indicators for Pharming Group NV?

The technical indicators for Pharming Group NV are in a Strong Buy position based on daily analysis, with 9 signals on buy indicators and 1 sell signals.

What Is PHARMa's 14-Day RSI?

The current Relative Strength Index (RSI) of PHARMa over the 14-day period is 55.654, which suggests that the stock is a Buy.

What Is PHARMa's MACD?

PHARMa's MACD is 0.033, which suggests that the stock is a Buy.

What Is PHARMa's 5-Day Moving Average?

PHARMa's 5-day moving average is 0.9461, suggesting that the stock is a Buy.

What Is PHARMa's 50-Day Moving Average?

PHARMa's 50-day moving average is 0.8662, suggesting that the stock is a Buy.

What Is PHARMa's 200-Day Moving Average?

PHARMa's 200-day moving average is 0.9914, suggesting that the stock is a Sell.

What Is the Fibonacci Pivot Point Performance Value for PHARMa?

The Fibonacci pivot point performance value for PHARMa is 0.9573.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.